TiGenix Partners With U.S. And European Patient Advocacy Groups Focused On...
Life Sciences Jobs ...
View ArticleLifeArc previously MRC Technology set to transform the medical research...
Investment will focus on new innovations in therapeutics for neurodegeneration antibiotic resistance cancer and respiratory diseases Newly rebranded UK medical research charity has also established two...
View ArticleJohnson & Johnson Innovation Announces New Collaborations Advancing...
NEW BRUNSWICK N.J. June 15 2017 PRNewswire Johnson & Johnson Innovation LLC today announced new collaborations that seek to develop potential treatments for diseases in urgent need of solutions...
View ArticleArena Pharmaceuticals to Present at JMP Securities Life Sciences Conference
SAN DIEGO June 15 2017 PRNewswire Arena Pharmaceuticals Inc. NASDAQ ARNA today announced that Amit Munshi the Company's President and Chief Executive Officer will present a corporate update at the JMP...
View ArticleImmune Pharmaceuticals Signs Agreement to Regain Worldwide Rights for Ceplene
NEW YORK June 15 2017 PRNewswire Immune Pharmaceuticals Inc. NASDAQ IMNP 'Immune' announced today that it has signed an agreement with Meda a Mylan NV company 'Mylan' to repurchase assets relating to...
View ArticleBiologics for Mucosal Healing in Crohn's Disease and UC
Using mucosal healing as a therapeutic endpoint this review aimed to determine the comparative efficacy of different classes of biologic therapy for treating Crohn's disease and ulcerative colitis....
View ArticleDrugs.com Releases Q2 Sales for Top 100 U.S. Prescription Drugs Humira Climbs...
NEW YORK Aug. 14 2013 PRNewswire Drugs.com the leading online clinical drug resource today released second quarter 2013 U.S. prescription sales data for the top 100 drugs. Since Q2 2012 Otuska's...
View ArticleEULAR 2017 Lilly's Taltz ixekizumab Demonstrated No Progression or Minimal...
INDIANAPOLIS June 16 2017 PRNewswire Eli Lilly and Company NYSE LLY announced today that the majority of patients with active psoriatic arthritis PsA treated with Taltz ixekizumab exhibited either no...
View ArticleCVS Caremark's Accordant Health Services Launches New MemberFocused Web Site
WOONSOCKET R.I. Aug. 8 2013 PRNewswire &160;CVS Caremark NYSE CVS announced today that Accordant Health Services has launched an updated web site and member portal which provides new features and...
View ArticleSanguine BioSciences Announces Distribution Partnership with AMS Biotechnology
VALENCIA Calif. Aug. 8 2013 PRNewswire &160;Sanguine BioSciences a biotechnology company enabling personalized medicine research today announced a distribution partnership with AMS Biotechnology...
View ArticleInnovative PublicPrivate Consortium Established To Define The Triggers Of...
SPRING HOUSE Pa. May 5 2014 PRNewswire &160;Janssen Research & Development LLC Janssen announced today the establishment of a Cooperative Research and Development Agreement CRADA with the...
View ArticleFor Moderate To Severe Crohn's Disease Surveyed Gastroenterologists Indicate...
BURLINGTON Mass. June 27 2013 PRNewswire Decision Resources one of the world's leading research and advisory firms for pharmaceutical and healthcare issues finds that a therapy that enables a greater...
View ArticleSoligenix Completes Phase 1 Clinical Study with SGX203 for the Treatment of...
PRINCETON N.J. June 28 2013 PRNewswire &160;Soligenix Inc. OTCQB SNGX Soligenix or the Company a clinical stage biopharmaceutical company focused on developing products to treat inflammatory...
View ArticleImmune Receives NASDAQ Compliance Letter
NEW YORK June 19 2017 PRNewswire Immune Pharmaceuticals Inc. NASDAQ IMNP the "Company" announced today that on June 15 2017 the Company received written notice from the Nasdaq that the Company has...
View ArticleNICE Approves Stelara for Crohn's Disease
NewsCrohns disease is an inflammatory bowel disease and can affect any part of the digestive system.
View ArticleAntitumor Necrosis and Inflammatory Bowel Disease
A The inflammatory bowel diseases are chronic relapsing inflammatory disorders of the gastrointestinal tract with a propensity to develop tissue damage including fibrosis and strictures penetrating...
View ArticleUK NICE recommends Janssens Ustekinumab treatment for Crohns disease
The UKs National Institute for Health and Care Excellence NICE has recommended Janssens Ustekinumab for the treatment of patients with moderatetosevere Crohns disease.
View ArticleUpdate on antitumor necrosis factor agents and other new drugs for...
The treatment of inflammatory bowel disease IBDulcerative colitis UC and Crohns disease CDhas evolved beyond surgery with the introduction of biologic agents primarily antibodies against...
View ArticleImmune Pharmaceuticals announces initiation of enrollment in clinical trial...
NEW YORK June 20 2017 PRNewswire Immune Pharmaceuticals NASDAQIMNP "Immune" a clinical stage biopharmaceutical company announced today that patient enrollment in a Phase III clinical trial evaluating...
View ArticleTakeda And TiGenix Announce That Swissmedic Has Accepted For Review The File...
Life Sciences Jobs ...
View Article